Ani Pharmaceuticals (ANIP) FCF Margin Growth (3y) (2013 - 2026)
Ani Pharmaceuticals (ANIP) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 460.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 460.00 |
| Mar 31, 2026 | 416.00 |
| Dec 31, 2025 | 2,190.00 |
| Sep 30, 2025 | 1,165.00 |
| Jun 30, 2025 | 4,954.00 |
| Mar 31, 2025 | 4,700.00 |
| Dec 31, 2024 | 3,551.00 |
| Sep 30, 2024 | 747.00 |
| Jun 30, 2024 | 1,375.00 |
| Mar 31, 2024 | -16,590.00 |
| Dec 31, 2023 | 4,758.00 |
| Sep 30, 2023 | 3,823.00 |
| Jun 30, 2023 | -3,037.00 |
| Mar 31, 2023 | 1,752.00 |
| Dec 31, 2022 | -1,444.00 |
| Sep 30, 2022 | -3,677.00 |
| Jun 30, 2022 | -2,801.00 |
| Mar 31, 2022 | -5,344.00 |
| Dec 31, 2021 | -6,611.00 |
| Sep 30, 2021 | -2,100.00 |